1. Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device
- Author
-
Hakho Lee, Hojeong Yu, Chang Yeol Lee, Jiyong Cheong, Jung Uk Lee, Jinwoo Cheon, Jae Hyun Lee, and Hyun-Jung Choi
- Subjects
0301 basic medicine ,Genetic testing ,Coronavirus disease 2019 (COVID-19) ,Chemistry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Biomedical Engineering ,Medicine (miscellaneous) ,RNA ,Bioengineering ,Publisher Correction ,Fluorescence ,Article ,Reverse transcriptase ,Computer Science Applications ,03 medical and health sciences ,Fluorescence intensity ,030104 developmental biology ,0302 clinical medicine ,Real-time polymerase chain reaction ,Nanoparticles ,030217 neurology & neurosurgery ,Biotechnology ,Biomedical engineering ,Point of care - Abstract
The current gold standard for COVID-19 confirmation is RT-PCR, which possesses high sensitivity and specificity, but a long turnaround time has been a drawback. Here, we introduce a nanoPCR platform that can yield breakthroughs in RT-PCR speed and decentralize the diagnostic testing. A key innovation is to exploit magneto-plasmonic nanoparticles for dual purposes: fast thermocycling through plasmonic heating and enhanced signal detection via magnetic fluorescence switch. We further integrated these functionalities into a portable system to streamline point-of-care (POC) COVID-19 diagnostics with a “one-step-finish” approach from sampling to result. When applied with clinical COVID-19 samples, nanoPCR achieved an analytical performance of sensitivity and specificity comparable to that of a benchtop instrument but completed the entire detection within 18 minutes (vs. 2.5 hours for regular RT-PCR), which makes it ideal for rapid POC diagnostics. This platform technology is readily scalable for higher throughput and expandable to other disease targets, promising broader impacts in on-site molecular testing.
- Published
- 2020
- Full Text
- View/download PDF